Fresenius Kabi unveils adenosine injection in prefilled syringesFresenius Kabi is the first company to offer adenosine in both vials and prefilled syringes. Endo launches authorized Proventil genericEndo’s Par Pharmaceutical is distributing the authorized generic of Merck's Proventil. FDA gives tentative nod for Perrigo’s generic Sernivo spray Betamethasone dipropionate had a market value of about $15 million for the 12 months ending February 2019, according to IQVIA. Armas Pharmaceuticals launches 2 generics Armas Pharmaceuticals is introducing generic Xeloda and Gleevec, which had a market value of roughly $108 million and $655 million, respectively. ANI Pharmaceuticals launches 2 generics Methylphenidate hydrochloride extended-release tablets have a market value of roughly $505 million, and erythromycin ethylsuccinate for oral suspension has a market value of $16 million. Apotex reportedly considering a sale Apotex's business is valued at roughly $3 billion, according to a Bloomberg report. FDA issues REMS guidance to spur generic drug development The FDA has clarified several factors that determine whether a Risk Evaluation and Mitigation Strategy is required for a drug. CREATES Act passes House Committee The House Energy and Commerce Committee voted 51-0 to pass the CREATES Act of 2019. FDA aims to drive competition on the insulin market The FDA announced a public hearing to advance access to insulin products, including biosimilar and interchangeable insulin products. Alembic gets FDA's green light for generic Cialis Tadalafil tablets have a market value of $1.8 billion for the twelve months ending December 2018. First Previous 193 194 195 196 197 Next Last
